Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	Maintenance Rituximab for Follicular Lymphoma Azacitidine Improves Survival in MDS Second Stem Cell Transplant Not Helpful in Myeloma

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
Phase IV Treatment Active Over 18 Other CZOL446ECN07
NCT00765687

Trial Description

Summary

A multicenter Prospective Study to assess the screening methods, parameter of NTX and the efficacy and safety of zoledronic acid treatment in addition to anti-tumor therapy in patients of non-small cell cancer with bone metastasis in china.

Eligibility Criteria

Inclusion Criteria:

1. Age >18, either sex

2. Histologically confirmed non-small cell cancer

3. One bone metastasis at least confirmed by imageology

4. Without receiving zoledronic acid

5. Life expectancy > 6 M

6. ECOG <= 2

7. Signed ICF

Exclusion Criteria:

1. Women who are pregnant or in lactation

2. Patients with hyperostosis

3. with brain metastasis(exception of those without symptom or with Metastasis Lesions under controlled

4. Previous or current treatment with any other bisphosphonates, bone- protecting, cytotoxic or targeted therapy

5. Severe co-morbidity of any type that may interfere with assessment of the patient for the study -

Trial Contact Information

Trial Lead Organizations/Sponsors

Sun Yat-Sen University First Hospital

Novartis Pharmaceuticals Corporation

Zhang Li, Master

Principal Investigator

Zhang Li, Master		Ph: 86-20-8734-3366(O)
		Email: zhangli6@mail.sysu.edu.cn

Trial Sites

China

GuangZhou

Sun Yat-Sen University Cancer Center

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00765687
Information obtained from ClinicalTrials.gov on March 18, 2009

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.